MoonLake Immunotherapeutics (MLTX)
NASDAQ: MLTX · Real-Time Price · USD
52.62
-1.68 (-3.09%)
At close: Sep 12, 2025, 4:00 PM EDT
53.67
+1.05 (2.00%)
After-hours: Sep 12, 2025, 7:36 PM EDT
MLTX Market Cap
MLTX has a market cap or net worth of $3.34 billion as of September 12, 2025. Its market cap has increased by 13.24% in one year.
Market Cap
3.34B
Enterprise Value
2.99B
1-Year Change
13.24%
Ranking
Category
Stock Price
$52.62
Market Cap Chart
Since February 14, 2022, MLTX's market cap has increased from $3.60M to $3.34B, an increase of 92,767.44%. That is a compound annual growth rate of 575.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 3.34B | -2.15% |
| Dec 31, 2024 | 3.41B | -5.66% |
| Dec 29, 2023 | 3.62B | 784.47% |
| Dec 30, 2022 | 409.26M | 11,274.54% |
| Feb 14, 2022 | 3.60M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.94B |
| Johnson & Johnson | 429.89B |
| AbbVie | 389.03B |
| UnitedHealth Group | 320.26B |
| AstraZeneca | 251.66B |
| Novartis AG | 247.58B |
| Novo Nordisk | 241.70B |
| Abbott Laboratories | 230.87B |